deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03520439

Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis (ETESRTA)

Mifepristone Versus Placebo to Treat Adenomyosis: a Double-blind, Multicentre，Randomized Clinical Trial

Sponsor: Anhui Province Cancer Hospital

Conditions Adenomyosis
Interventions Mifepristone Placebo
Updated 9 times since 2018 Last updated: Oct 1, 2019 Started: May 19, 2018 Primary completion: Jul 31, 2019 Completion: Oct 1, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03520439, this PHASE2/PHASE3 trial focuses on Adenomyosis and remains completed. Sponsored by Anhui Province Cancer Hospital, it has been updated 9 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotNot Yet Recruiting~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshotRecruiting~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshotRecruiting~Dec 2018 – ~Apr 2019 · 4 months · monthly snapshotRecruiting~Apr 2019 – ~Nov 2019 · 7 months · monthly snapshotRecruiting~Nov 2019 – ~Jan 2021 · 14 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Nov 2019 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

    Status: Recruiting → Completed

  5. Apr 2019 — Nov 2019 [monthly]

    Recruiting PHASE2_PHASE3

▶ Show 4 earlier versions

  1. Dec 2018 — Apr 2019 [monthly]

    Recruiting PHASE2_PHASE3

  2. Aug 2018 — Dec 2018 [monthly]

    Recruiting PHASE2_PHASE3

  3. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Not Yet Recruiting → Recruiting

  4. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Anhui Province Cancer Hospital
  • First Affiliated Hospital of Wenzhou Medical University
  • Huzhou Maternity and Child Care Hospital
  • Jiaxing Maternity and Child Health Care Hospital
  • Jinhua Municipal Central Hospital
  • Ningbo Maternity and Child Care Hospital
  • Second Affiliated Hospital, School of Medicine, Zhejiang University
  • Shaoxing People's Hospital
  • Shaoxing Women and Children's Hospital
  • Sir Run Run Shaw Hospital
  • Taizhou First People's Hospital
  • The Affiliated Hospital of Medical School of Ningbo University
  • The Central Hospital of Lishui City
  • The People's Hospital of Quzhou
  • Zhoushan Maternity and Infant Hospital
  • xinmei zhang
Data source: Women's Hospital School Of Medicine Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations